share_log

Stocks of the Hour: Infinity Lithium Corp, TG Metals, 4DMedical

Stocks of the Hour: Infinity Lithium Corp, TG Metals, 4DMedical

時段股票:無限鋰業公司、TG Metals、4dMedical
sharecafe ·  2023/11/13 08:50

Infinity Lithium Corporation (ASX:INF) has advised a grant funding of €18.8 million has been awarded to Tecnología Extremeña del Litio ('TEL') for the advancement of the San José Lithium Project. Infinity's Managing Director and CEO, Ryan Parkin, commented "These first funding commitments for the processing of critical raw materials in Spain places the Company at the forefront of future funding pathways at both the national and European level." Shares are trading 41.18 per cent higher at 12 cents.

Infinity Lithium Corporation(澳大利亞證券交易所股票代碼:INF)表示,已向Tecnologi'a Extremena del Litio(“TEL”)提供了1,880萬歐元的補助金,用於推進聖何塞鋰項目。Infinity董事總經理兼首席執行官Ryan Parkin評論說:“西班牙關鍵原材料加工的首批融資承諾使公司處於國家和歐洲層面未來融資途徑的最前沿。”股價上漲41.18%,至12美分。

TG Metals Limited (ASX:TG6) has provided an update on lithium exploration activities at the Lake Johnston Lithium Nickel Gold Project, located in the Lake Johnston greenstone belt in WA. TG Metals CEO, Mr. David Selfe stated; "Since the discovery of the spodumene pegmatites at Burmeister, the deposit models we have been considering have been based on the Earl Grey lithium mine area.....We are eagerly anticipating the next drilling results from Burmeister which we expect assays back in the next 2 weeks." Shares are trading 16.85 per cent higher at $1.04.

TG Metals Limited (ASX: TG6) 提供了位於華盛頓州約翰斯頓湖綠巖帶的約翰斯頓湖鋰鎳金項目鋰勘探活動的最新情況。TG Metals首席執行官戴維·塞爾夫表示:“自從在Burmeister發現鋰輝石偉晶岩以來,我們一直在考慮的礦牀模型一直基於伯爵格雷鋰礦區... 我們熱切期待Burmeister的下一次鑽探結果,我們預計將在未來兩週內進行化驗。”股價上漲16.85%,至1.04美元。

4DMedical Limited (ASX:4DX) announced the inclusion of the company's XV LVAS procedure to the U.S. Centers for Medicare & Medicaid Services (CMS) annual, final payment rates for hospital outpatient-based services, effective 1 January 2024. 4DMedical MD/CEO and Founder Andreas Fouras said: I am very excited by this progress in the commercialisation of our technology, and the positive impact this reimbursement decision will have upon doctors and their patients." Shares are trading 52.17 per cent higher at 70 cents.

4dMedical Limited (ASX: 4DX) 宣佈,自2024年1月1日起,將公司的XV LVAS程序納入美國醫療保險和醫療補助服務中心 (CMS) 醫院門診服務的年度最終支付率。4dMedical 總經理/首席執行官兼創始人安德烈亞斯·富拉斯表示:我對我們技術商業化的這一進展以及這一報銷決定將產生的積極影響感到非常興奮醫生和他們的病人。”股價上漲52.17%,至70美分。

1x1.png?futu_img_keep_extra_domain=1

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論